Loading page...
Loading page...
NCP-IVS III GP ApS · Copenhagen, Denmark
Visit the fund website ↗2008-vintage biotech investment fund managed by NB Capital in Copenhagen, with EIF as its sole limited partner. Targets biotechnology, pharmaceuticals, and oncology across the Nordic region. PitchBook records this fund as closed. Registered as Nordic Biotech Opportunity Fund K/S under Danish company number 31262488.
Choose your AI and follow the walkthrough. Your free EUACC account connects the two.
Illustrated walkthrough
https://www.euacc.ai/api/mcpWorks on every Claude plan, including Free (one custom connector). On Team and Enterprise, an Owner adds it.
On a phone, add it at claude.ai in your browser. It then shows up in the Claude app the next time you sign in.
Use EUACC to explore “Nordic biotech opportunity fund ks” (https://www.euacc.ai/investors/nordic-biotech-opportunity-fund-ks). Help me assess investor fit and prepare questions using the available fund profiles. Cite the available sources and flag missing or outdated information.